This track welcomes papers addressing the latest advances in the fundamental and applied studies of product and process development of both established and emerging novel pharmaceutical modalities. Examples include biologics and other large molecules, oligos, peptides, ADCs, gene therapy, and other new modalities in pharmaceuticals. Scientists and engineers involved in upstream and downstream development, processing, scale-up and transfer of these products are invited. Topics may include, but not limited to, cell culture preparation/fermentation, separation/purification, formulation/buffer exchange, fill/finish, and finished device/delivery. Presentations in this Advances in New Modalities: New Modalities & Technologies session will focus on novel therapeutic modalities, delivery strategies, or technologies related to therapeutic molecules.
03:30 PM
Yanxi Yang, Shelby Vexler, Irene Chen
03:51 PM
04:12 PM
Hursh Sureka, Jiajie Huo, Shelby McCowen, Donggeon Nam, Nicolas Cuniere, Selin Aytar, Michael Smith
04:33 PM
Tanvi Varadkar, Jiashuai Zhang, Zhuoxin Zhou, Alyssa Fairgrieve, Lufang Zhou, X. Margaret Liu
04:54 PM
Hyeyoung Kwon, Greg Thurber
05:15 PM
Suneha Patil, Zoe Whiteley, Esther Osarfo-Mensah, Duncan Craig, Stefan Guldin, Asterios Gavriilidis
05:36 PM
Shekhar Viswanath, Jingyao Wang, Shankar Vaidyaraman, Bhoja Kandela